Intratumoral BO-112 with pembrolizumab shows benefit in advanced melanoma refractory to anti-PD-1 therapy

Recurrent non-invasive breast tumours may not always be related to the primary lesion

Real-world increase in biomarker testing in lung cancer

EGFR testing: Best practice for NSCLC patients with exon 20 insertions

Real-world evidence on PET use in Hodgkin lymphoma: An Argentinian perspective

An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validation in NRG/RTOG 9408

OncoAlert and ecancer weekly round up for February 7th - 13th, 2022

Eye metastasis in breast cancer: Case report and review of literature

Update on the new EUSOMA quality indicators for breast cancer

Lung cancer in India

Tumour agnostic treatments in GI cancer

OncoAlert Colloquium Day 6: Gynaecological oncology, IGCS and ESO